Download Free Obamacare 101 Book in PDF and EPUB Free Download. You can read online Obamacare 101 and write the review.

"A graphic explanation of the PPACA act"--Provided by publisher.
The Patient Protection and Affordable Care Act (ACA) was designed to increase health insurance quality and affordability, lower the uninsured rate by expanding insurance coverage, and reduce the costs of healthcare overall. Along with sweeping change came sweeping criticisms and issues. This book explores the pros and cons of the Affordable Care Act, and explains who benefits from the ACA. Readers will learn how the economy is affected by the ACA, and the impact of the ACA rollout.
ObamaCare, otherwise known as the Affordable Care Act (ACA), has become law in the United States and has lead to a major reform of the healthcare industry. Although the law has received wide media coverage, the majority of our citizens still do not understand the basic tenets of the law. This book simplifies the main provisions of ObamaCare, using a question and response format that reflects the daily struggles and interactions with processes involved in ObamaCare coverage, while using scenarios to reinforce understanding. The reader will be introduced to the health exchange, including information on available subsidies based on income, penalty tax and how one qualifies for Medicaid under ObamaCare. Reviewing the content of this book will allow the reader to understand the goals of universal coverage, essential health benefits, and qualification criteria for tax credits. It is a must-read for those who want to benefit the most from the ObamaCare Act.
Explores the intricacies of, and offers practical guidance on the Patient Protection and Affordable Care Act.
The Patient Protection and Affordable Care Act (ACA) was designed to increase health insurance quality and affordability, lower the uninsured rate by expanding insurance coverage, and reduce the costs of healthcare overall. Along with sweeping change came sweeping criticisms and issues. This book explores the pros and cons of the Affordable Care Act, and explains who benefits from the ACA. Readers will learn how the economy is affected by the ACA, and the impact of the ACA rollout.
"[This book is] the most authoritative assessment of the advantages and disadvantages of recent trends toward the commercialization of health care," says Robert Pear of The New York Times. This major study by the Institute of Medicine examines virtually all aspects of for-profit health care in the United States, including the quality and availability of health care, the cost of medical care, access to financial capital, implications for education and research, and the fiduciary role of the physician. In addition to the report, the book contains 15 papers by experts in the field of for-profit health care covering a broad range of topicsâ€"from trends in the growth of major investor-owned hospital companies to the ethical issues in for-profit health care. "The report makes a lasting contribution to the health policy literature." â€"Journal of Health Politics, Policy and Law.
A New Era in U.S. Health Care demystifies the Affordable Care Act for unfamiliar readers, setting an agenda for lawmakers and the health industry alike. It focuses on four key issues that will determine the success of this 2010 legislation: the use of state-run Medicaid programs to expand access to insurance; the implementation process; the creation of health insurance exchanges; and the introduction of a new organizational form, accountable care organizations.
Not five minutes after the Affordable Care Act (ACA) was signed into law, in March 2010, Virginia’s attorney general was suing to stop it. And yet, the ACA rolled out, in infamously bumpy fashion, and rolled on, fought and defended at every turn—despite President Obama’s claim, in 2014, that its proponents and opponents could finally “stop fighting old political battles that keep us gridlocked.” But not only would the battles not stop, as Obamacare Wars makes acutely clear, they spread from Washington, DC, to a variety of new arenas. The first thorough account of the implementation of the ACA, this book reveals the fissures the act exposed in the American federal system. Obamacare Wars shows how the law’s intergovernmental structure, which entails the participation of both the federal government and the states, has deeply shaped the politics of implementation. Focusing on the creation of insurance exchanges, the expansion of Medicaid, and execution of regulatory reforms, Daniel Béland, Philip Rocco, and Alex Waddan examine how opponents of the ACA fought back against its implementation. They also explain why opponents of the law were successful in some efforts and not in others—and not necessarily in a seemingly predictable red vs. blue pattern. Their work identifies the role of policy legacies, institutional fragmentation, and public sentiments in each instance as states grappled with new institutions, as in the case of the exchanges, or existing structures, in Medicaid and regulatory reform. Looking broadly at national trends and specifically at the experience of individual states, Obamacare Wars brings much-needed clarity to highly controversial but little-understood aspects of the Affordable Care Act’s odyssey, with implications for how we understand the future trajectory of health reform, as well as the multiple forms of federalism in American politics.
The Affordable Care Act, or Obamacare as it has come to be known, has split American society, politics and media like no other subject in living memory. It is not just the concept itself as there is a pretty general recognition that healthcare needed reforming in the US. It is more the nature and implications of the system that seem to have stirred up a veritable hornets nest of protest - even outrage. Some will see in the extreme reaction of the Republican party, especially the more right-wing elements, an idealogical stance that has more to do with a hatred of big government, state spending and what they see as taking away individual choice. Some will go further and say that it is an almost pathological hatred of this presidential regime and the current Democrat culture which drives opposition to almost destructive - and maybe self-destructive - lengths. A more balanced view might be that Obamacare has both good and bad aspects but that something has to be done and the resultant impact might be necessary pain for some for a period. Whether the system delivers only time will tell. The same goes for whether it will bankrupt the country, cost jobs and competitiveness and generally weaken the US economy. Both sides of the argument have got a lot to lose - and potentially - gain if the pendulum swings their way. It will be an interesting journey.
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.